Even when the NIH funds the research, the resulting drugs/procedures/patents are rarely owned by the Federal Government anymore because of the Bayh-Dole Act.
In addition to public funding of NIH research, it takes a commercial company (pharma) well beyond $1 billion to get one successful drug on the market.